Skip to main content
Australian Prescriber logoLink to Australian Prescriber
. 2019 Jul 4;42(4):145. doi: 10.18773/austprescr.2019.053

Prescribing for transgender patients [Correction]

PMCID: PMC6698243  PMID: 31427849

The article on prescribing for transgender patients (Aust Prescr 2019;42:10-3) has been corrected.

In the second paragraph of the ‘Monitoring’ section, the target estradiol level for transwomen on treatment should be 400–700 pmol/L (not 400–700 mmol/L).


Articles from Australian Prescriber are provided here courtesy of Therapeutic Guidelines Ltd

RESOURCES